Clinical Trial Update: Phase 2 Trial of Nab-paclitaxel Plus S-1 vs Gemcitabine Plus Cisplatin as 1-line Chemotherapy of Patients With Local Advanced and/or Metastatic Transitional Cell Carcinoma of Urothelial Tract [Phase 2]

View source ↗

Summary

A phase 2 trial comparing nab-paclitaxel plus S-1 versus gemcitabine plus cisplatin as first-line therapy for locally advanced or metastatic urothelial carcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma Transitional Cell
• Urothelial Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Carcinoma, Transitional Cell | Phase 2 | Status: COMPLETED